LakeShore Biopharma Competitors and Similar CompaniesClear all

LakeShore Biopharma's competitors and similar companies include UCB.
LakeShore Biopharma
LakeShore Biopharma
LakeShore Biopharma (湖岸生物, formerly known as Yisheng Biopharma, YS Biopharma, 辽宁依生生物制药有限公司) is a company engaged in the development, production, marketing, and sale of vaccines and therapeutic biologics for infectious diseases and cancer.
UCB
UCB
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
Founding Date
Founding Date
2002
Founding Date
1928
Type
Type
Public
Type
Public
Tags
Locations
Locations
Beijing, CN HQ
Gaithersburg, US
Locations
Brussels, BE HQ
Melbourne, AU
Vienna, AT
Braine L'alleud, BE
Braine L'alleud, BE
Leuven, BE
São Paulo, BR
see more
Employees
Employees
773
Employees
9,052
Valuation ($)
Valuation ($)
192.1 m
Valuation ($)
34.3 b

Financial

Revenue (est.)
Revenue (est.)
¥615m (FY, 2025)
Revenue (est.)
€7.4b (FY, 2025)
Cost of goods
Cost of goods
¥71.1m (FY, 2025)
Cost of goods
€1.4b (FY, 2025)
Gross profit
Gross profit
¥543.8m (FY, 2025)
Gross profit
€7.2b (FY, 2025)
Net income
Net income
(¥100m) (FY, 2025)
Net income
€1.6b (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

UCB
HQ
Brussels, BE
Employees
9,052

UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.

View company